97196 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45
#2Vascular Constructs
#3METHODS FOR ENHANCING EFFICACY OF THERAPEUTIC IMMUNE CELLS
#4HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF
#5BISPECIFIC ANTIBODY FOR T-CELL MODULATION
#6ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF
#7COMPOSITIONS AND METHODS COMPRISING MODIFIED CHIMERIC ANTIGEN RECEPTOR (CAR) MACROPHAGES
#8SPECIFIC DOSAGE REGIMEN FOR HEMIBODY THERAPY
#9PREPARATION METHOD AND USE OF NON-NATURAL ANTI-HUMAN CD45RA MURINE CHIMERIC ANTIGEN RECEPTOR
#10ANTI-HUMAN CD45RC ANTIBODIES AND USES THEREOF
#11Engineered Pan-Leukocyte Antigen CD45 to Facilityate CAR T Cell Therapy
#12MULTIFUNCTIONAL IMMUNE CELL THERAPIES
#13IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS
#14COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#15HUMANIZED ANTI-CD45 ANTIBODIES
#16RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF
#17METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE
#18Anti-CD45 antibodies and conjugates thereof
#19COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#20ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTION WITH GENE-EDITED CELL-BASED THERAPIES
#21MULTIFUNCTIONAL IMMUNE CELL THERAPIES
#22FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
#23Humanized anti-CD45 antibodies
#24COMPOSITIONS AND METHODS FOR ALLOGENEIC TRANSPLANTATION
#25BINDING MOLECULES THAT MULTIMERISE CD45
#26CD45 BINDING MOLECULES AND METHODS OF USE
#27COMPOSITIONS AND USES OF CD45 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
#28COMPOSITIONS AND METHODS FOR MODULATION OF SIRPALPHA-MEDIATED SIGNALING
#29ANTIBODY MOLECULES WHICH BIND CD45
#30USE OF CD83 IN COMBINATION THERAPIES
#31CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF
#32ANTIBODY COMBINATION FOR ONE-STEP SCREENING AND/OR DIAGNOSIS OF CLONAL DISEASES AND RELATED APPLICATION
#33PERICYTE-SPARING THERAPY
#34RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE THEREOF
#35METHODS FOR ENHANCING EFFICACY OF THERAPEUTIC IMMUNE CELLS
#36COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF
#37Methods for enhancing efficacy of therapeutic immune cells
#38DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION
#39ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
#40PROTEASE-ACTIVATING CD45-GATE CAR
#41CELL SURFACE COUPLING OF NANOPARTICLES
#42Anti-CD45 Antibody Drug Conjugates and Uses Thereof
#43STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS
#44USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY
#45Anti-human CD45RC antibodies and uses thereof
#46COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER
#47Compositions and methods for non-myeloablative conditioning
#48Anti-CD45 antibodies and conjugates thereof
#49Vascular constructs
#50BISPECIFIC AFFINITY REAGENT AND RELATED METHODS FOR PRETARGETED RADIOIMMUNOTHERAPY AGAINST CD45+ CELL
#51Cell surface coupling of nanoparticles
#52MULTISPECIFIC MOLECULES THAT BIND TO MYELOPROLIFERATIVE LEUKEMIA (MPL) PROTEIN AND USES THEREOF
#53ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJCTION WITH ACT-BASED CANCER THERAPIES
#54DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION
#55TREATMENT OF MONOGENIC DISEASES WITH AN ANTI-CD45RC ANTIBODY
#56STIMULATION OF T REGULATORY CELLS BY CANNABIDIOL AS A MEANS OF TREATING ARTHRITIS AND AUTOIMMUNITY
#57Methods for Enhancing Efficacy of Therapeutic Immune Cells
#58CHIMERIC RECEPTOR
#59Multifunctional immune cell therapies
#60Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
#61FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
#62COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#63FGFR3 binding molecules
#64T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
#65METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES
#66Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof
#67FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
#68Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
#69Chimeric antigen receptors (CARs), compositions and methods thereof
#70Compositions and methods for non-myeloablative conditioning
#71Chimeric antigen receptors (CARs), compositions and methods thereof
#72MOLECULES WITH SPECIFICITY FOR CD45 AND CD79
#73Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex
#74COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#75Stabilized radio-labeled anti-CD45 immunoglobulin compositions
#76Dual antigen-induced bipartite functional complementation
#77Segregation Modulation for Immunotherapy
#78Anti-PD-1 antibodies and methods of treatment
#79Stabilized radiolabeled anti-CD45 immunoglobulin compositions
#80Methods for the depletion of cells
#81Vascular constructs
#82Compositions and methods for non-myeloablative conditioning
#83Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer
#84Methods of identifying immune cells in PD-L1 positive tumor tissue
#85COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#86Infusion administration of conjugated monoclonal antibodies
#87FGFR3 binding molecules
#88Antibody molecules which bind CD45
#89Compositions and Methods for the Capture and Characterization of Circulating Tumor Cells
#90Antibody molecules which bind CD79
#91Chimeric antigen receptors (CARs), compositions and methods of use thereof
#92CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
#93Methods for enhancing efficacy of therapeutic immune cells
#94Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles
#95Stabilized radiolabeled anti-CD45 immunoglobulin compositions
#96T-cell redirecting bispecific antibodies for treatment of disease
#97AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG
#98Molecules with specificity for CD45 and CD79
#99Cell surface coupling of nanoparticles
#100Direct immunohistochemistry assay
#101COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#102T-cell redirecting bispecific antibodies for treatment of disease
#103Compositions and methods for non-myeloablative conditioning
#104Use of CD83 in Combination Therapies
#105COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#106T-cell redirecting bispecific antibodies for treatment of disease
#107Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles
#108Humanized antibody or fragment thereof specific for CD45R0
#109Method and kit for determining-antibody sensitivity and clone cell strain
#110T-cell redirecting bispecific antibodies for treatment of disease
#111BISPECIFIC ANTIBODIES
#112COMPOSITIONS AND METHODS TO INHIBIT STEM CELL AND PROGENITOR CELL BINDING TO LYMPHOID TISSUE AND FOR REGENERATING GERMINAL CENTERS IN LYMPHATIC TISSUES
#113Therapeutic Binding Molecules
#114Induction of Tolerogenic Phenotype in Mature Dendritic Cells
#115CCR2 ANTAGONISTS FOR CHRONIC ORGAN TRANSPLANTATION REJECTION
#116Demibodies: dimerization-activated therapeutic agents
#117BISPECIFIC ANTIBODIES
#118Devices, compositions and methods for the protection and repair of cells and tissues
#119CHIMERIC PANCREAS
#120Methods of implanting mesenchymal stem cells for tissue repair and formation
#121Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10
#122Method for the discrimination and isolation of mammary epithelial stem and colony-forming cells
#123Compositions and methods for treating haematological proliferative disorders
#124Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells
#125Rapamycin and il-10 for the treatment of immune diseases
#126Therapeutic binding molecules
#127Bispecific antibodies
#128Methods for treating HIV infected subjects
#129Methods of implating mesenchymal stem cells for tissue repair and formation
#130Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
#131Activation and expansion of cells
#132Activation and expansion of cells
#133Therapeutic binding molecules
#134Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues